Ocular Therapeutix, Inc.
News
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globe Newswire BEDFORD, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, Ocular ), a biopharmaceutical company committed to improving vision in the real world through the...\n more…
Zurcher Kantonalbank Zurich Cantonalbank Acquires 28,309 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL)
Ticker Report Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL - Free Report) by 757.9% during the second quarter, according to the company in its...\n more…
Ocular Therapeutix to Present at September Retina Meetings
Globe Newswire BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, Ocular ), a biopharmaceutical company committed to improving vision in the real world through the...\n more…
Ocular Therapeutix to Present at Two Investor Conferences in September
Globe Newswire BEDFORD, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, Ocular , the Company ), a biopharmaceutical company committed to improving vision in the real world...\n more…
Have Ocular Therapeutix Insiders Been Selling Stock?
Simply Wall St We'd be surprised if Ocular Therapeutix, Inc. ( NASDAQ:OCUL ) shareholders haven't noticed that the Executive Chairman...\n more…
Sanjay Nayak Sells 1,832 Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL) Stock
Ticker Report Ocular Therapeutix, Inc. (NASDAQ:OCUL - Get Free Report) insider Sanjay Nayak sold 1,832 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at...\n more…